Effects and application of artemisinin and its derivative in inhibition of platelet-derived growth factor receptor A
A technology of artemisinin derivatives and growth factor receptors, which is applied in the field of biomedicine and can solve the problems of unclear targets, related signaling pathways and mechanism of action
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0112] Artemisinin and its derivatives directly bind to PDGFRα, inhibit its phosphorylation activity, and promote its degradation
[0113] Using PDGFRα in vitro kinase experiments, surface plasmon resonance, computer-aided isotype modeling and reverse docking experiments and other advanced biological techniques and methods such as molecular pharmacology and biophysics, it is confirmed that artemisinin derivatives can directly bind to PDGFRα, inhibit The receptor tyrosine kinase activity of PDGFRα. At the same time, studies have found that dihydroartemisinin can inhibit the protein stability of PDGFRα in PDGFRα-positive cells and promote its ubiquitin-dependent degradation process.
[0114] figure 1 It shows that artemisinin and its derivatives can directly bind to PDGFRα, PDGFRα is the direct target of artemisinin and its derivatives, and can inhibit its phosphorylation activity and promote its degradation. In vitro kinase experiments showed that artemisinin and its derivativ...
Embodiment 2
[0116] Artemisinin and its derivatives inhibit the growth and metastasis of PDGFRα-positive tumor cells
[0117] The orthotopic ovarian cancer xenograft model in nude mice was used to study the anti-ovarian cancer activity of dihydroartemisinin in animals. The luciferase-labeled human ovarian cancer cells A2780 were injected into the peritoneal cavity of Balb-c nude mice to establish an orthotopic model of ovarian cancer in nude mice, and then treated with dihydroartemisinin: control group (normal saline), low-dose group ( DHA 10mg / kg). The high-dose group (DHA 25mg / kg) was treated five times a week, with a two-day break, for a total of 6 weeks of treatment. During the period, an in vivo imaging system was used to observe the growth and metastasis of ovarian cancer in mice.
[0118] Through a series of studies at the cell level and animal level, it has been shown that artemisinin derivatives can effectively inhibit the growth, migration and invasion of PDGFRα-positive tumor ...
Embodiment 3
[0123] Sensitization of artemisinin and its derivatives with first-line chemotherapeutics
[0124] Artemisinin and dihydroartemisinin alone in vitro can significantly inhibit the growth, proliferation, migration and invasion of ovarian cancer and liver cancer cells. In this example, whether it has a chemosensitizing effect was tested. Artemisinin and dihydroartemisinin combined with gemcitabine respectively acted on human liver cancer cells HepG2 and Hep3B, and combined with carboplatin on ovarian cancer A2780 and OVCAR3 To observe the inhibitory effect of combined drugs on cell growth. result( Figure 5 )As follows:
[0125] HepG2 and Hep3B cells were treated with 10 μmol / L artemisinin or dihydroartemisinin alone or combined with 10 μg / L gemcitabine for 48 hours, and quantitative detection of cell apoptosis was carried out according to the above method. Specifically, gemcitabine alone acts on HepG2, and Hep3B cells show a certain apoptosis-promoting effect ( Figure 5 a),...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com